Diversified Healthcare Trust – (NASDAQ:DHCNI) Short Interest Down 65.9% in July

Diversified Healthcare Trust – (NASDAQ:DHCNI) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totaling 18,696 shares, a drop of 65.9% from the June 30th total of 54,805 shares. Based on an average trading volume of 14,429 shares, the short-interest ratio is presently 1.3 days.

Diversified Healthcare Trust Stock Down 1.1%

Shares of NASDAQ:DHCNI traded down $0.20 during midday trading on Tuesday, reaching $17.93. The company’s stock had a trading volume of 6,479 shares, compared to its average volume of 62,373. The firm has a 50 day moving average price of $18.22 and a two-hundred day moving average price of $17.75. Diversified Healthcare Trust has a fifty-two week low of $15.61 and a fifty-two week high of $19.09.

Diversified Healthcare Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Saturday, August 1st. Shareholders of record on Wednesday, July 15th will be paid a $0.3516 dividend. The ex-dividend date of this dividend is Wednesday, July 15th. This represents a $1.41 annualized dividend and a yield of 7.8%.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.